SMTL ID : 4rll.1

Crystal structure of human CK2alpha in complex with the ATP-competitive inhibitor 4-[(E)-(fluoren-9-ylidenehydrazinylidene)-methyl] benzoate

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.85 Å

Oligo State

monomer

Ligands

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.1: 9 residues within 4Å: Chain A: Q.36, Y.39, L.41, V.67, I.69, V.101, D.103, P.104, A.110 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:Y.39, A:L.41, A:D.103, A:D.103

1 x E91: 4-[(E)-(9H-fluoren-9-ylidenehydrazinylidene)methyl]benzoic acid(Non-covalent)

E91.2: 9 residues within 4Å: Chain A: L.45, V.66, K.68, F.113, V.116, N.118, M.163, I.174, D.175 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.45, A:V.66, A:F.113, A:I.174, A:I.174 Hydrogen bonds: A:D.175 Water bridges: A:K.68, A:W.176 Salt bridges: A:K.68

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Guerra, B. et al., Protein kinase CK2 inhibition is associated with the destabilization of HIF-1 alpha in human cancer cells. Cancer Lett (2015)

Release Date

2014-12-17

Peptides

Casein kinase II subunit alpha: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Casein kinase II subunit alpha

Related Entries With Identical Sequence